Dr Anna Partyka-Opiela is an attorney-at-law admitted to practice in Poland, a partner at Rymarz Zdort Maruta and the head of the Compliance, Forensic and ESG practices.
Leading the Compliance team within the Life Sciences practice, she has over 15 years of experience in advising on compliance, whistleblowing, ethics, corruption prevention, AML and legal communication (Legal Design). She provides ongoing consultancy services in the fields of corruption prevention and compliance, with a particular focus on issues related to process transparency, communication, and the redesign and optimisation of compliance systems.
Anna has supervised numerous projects involving the implementation of comprehensive compliance systems, including in relation to ISO standards, whistleblowing, AML, sanctions regulations and the proper functioning of supply chains. She also has many years of experience in the areas of compliance and investigative audits, as well as fraud and abuse risk management.
Anna also advises on the legal aspects of the manufacturing, import, distribution and marketing of cosmetics, hygiene products, household chemicals and biocides.
Anna also leads projects dealing with Legal Design and governance consulting in ESG projects. She is a member of the Compliance Committee of the WSE and a member of the Innovators Council of the Polish ESG Association.
Anna earned her doctorate in law in 2010 and was admitted to the bar in 2015.
Anna is a laureate of the Compliance Advisor of the Year 2020 award by the Compliance Institute. Also, Anna was shortlisted in the fourth edition of a list of the most outstanding Polish women lawyers organised by Forbes Women Poland in cooperation with the Women in Law Foundation.
30 January 2024
European Union countries, including Poland, are required to transpose the provisions of the Whistleblower Directive into their legislation as well as implement new procedures related to whistleblowing...
9 November 2023
The law firm of Rymarz Zdort Maruta, in line with its strategy, is continuing its dynamic growth by expanding the scope of support it provides to also cover the Life Sciences sector. Over the coming m...